ADR and Monaghan

From Monoghan website ;

The adoption of reimbursement for remote patient monitoring in the US has accelerated during COVID-19. By combining the Hailie® platform with Monaghan’s market leading AEROCHAMBER® Valved Holding Chamber in Asthma and AEROBIKA® device in COPD. The introduction of the Hailie® platform and technology will begin with eight specialist respiratory centres across six states in November as the precursor to wider commercialisation planned from Q2 calendar 2021.

ADR Hailie® platform and sensors placed with customers and fully supported by Monaghan’s professional sales and clinical team.

“The addition of Adherium’s Hailie® technology to our existing portfolio provides our highly experienced sales team with an additional opportunity to engage with customers and offer a digital respiratory solution at a time when remotely managing patients is more critical than ever,” commented William Seitz, VP Sales and Marketing, Monaghan Medical. “This phased introduction will involve truly engaging with our customers to enable Monaghan to continue to deliver value to providers, payers and patients across the US.”

ADR ann 17/8/21

Before relocating from the USA, I was actively using the time to be leading from the front travelling to business meetings with partners in the US including Monaghan Medical Corporation, the wholly owned subsidiary of Trudell Medical, and HGE Health. In addition, I am developing further partner and customer opportunities in line with our go-to-market strategy.

9/9/2021 ADR ann
Adherium receives U.S. FDA 510(k) clearance for next generation Hailie® sensor with physiological measures

Can this FDA approval be the final stamp to begin commercialise Hailie sensor after trialling at the 8 specialist respiratory centres in US and meeting prior arrived in aus to launch it??

Could be an exciting next couple of wks for more news flows.